A Study of Palbociclib With Exemestane Plus GnRH Versus Capecitabine in Premenopausal Women With HR+ MBC

NCT02592746 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

182

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Breast Cancer

Interventions

DRUG: Palbociclib
DRUG: Exemestane
DRUG: Leuprolide Acetate
DRUG: Capecitabine

Sponsor

Samsung Medical Center